Exceeding Challenging Milestones Through Teamwork and Innovation: A Cardiovascular Case Study

A small biopharmaceutical company, developing a novel therapeutic platform, engaged Labcorp Drug Development to set up and conduct a global, Phase III, pivotal clinical trial on a promising treatment for a rare genetic cardiovascular disease. The sponsor had pressing corporate milestones, the first of these involving entering the first patient into the study within six months of award announcement. A major impediment was the fact that a study in this rare disease involving a rival molecule had already engaged premier sites.